Join our community of smart investors

Could a slimmer Croda make for a more attractive investment?

The chemicals specialist has launched a strategic review of its performance technologies and industrial chemicals businesses
May 12, 2021
  • The group is looking to focus on its faster-growing personal care and life sciences divisions
  • A review of its more cyclical businesses could see them demerged or sold

Specialty chemicals company Croda International (CRDA) has proved to be a high-quality and dependable holding for investors over the past decade. And amid the turbulence of the pandemic, it has outperformed many of its domestic and international peers, including Elementis (ELM) and Swiss flavour and fragrance giant Givaudan (CH:GIVN).

This is subscriber only content
Start your trial to keep reading
PRINT AND DIGITAL trial

Get 12 weeks for £12
  • Essential access to the website and app
  • Magazine delivered every week
  • Investment ideas, tools and analysis
Have an account? Sign in